Overview
TATAA Biocenter is a GLP-accredited CRO specializing in bioanalytical services for cell and gene therapies, including qPCR, dPCR, NGS, and proteomics. They provide biomarker discovery, assay validation, biodistribution, PK/PD analysis, and immune monitoring compliant with FDA, EMA, and GCLP standards. Their services support oligonucleotide drugs like mRNA, siRNA, ASOs, and CRISPR from preclinical to clinical stages.
Frequently asked questions
- What bioanalytical technologies does TATAA Biocenter offer?
- TATAA Biocenter offers qPCR, dPCR, NGS, nucleic acid extraction, and quantitative proteomics for biomarker analysis, mutation detection, and immune profiling in cell and gene therapies.
- What regulatory accreditations does TATAA Biocenter hold?
- They are GLP-accredited, GCLP-compliant, ISO/IEC 17025:2017 certified, and meet FDA and EMA expectations for bioanalysis in drug development.
- What therapeutic areas and geographies does TATAA Biocenter serve?
- TATAA focuses on cell and gene therapies, RNA therapeutics, ASOs, and precision medicine, operating from a state-of-the-art facility in Gothenburg, Sweden, serving global biopharma clients.